Evidence exists for a lower tumor risk in Alzheimer's, Huntington's, and Parkinson's diseases,18, 19 whereas no difference could be found in overall ALS patients compared to the general population.20 However, due to the low prevalence of FUS mutations, a possible cancer hazard could be masked. Here, FUS is linked to neoplasm.